Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
A drug that's currently being used to treat psoriasis.
Saw an ad for Humira (adalimumab) for treating psoriasis (by subcutaneous injection), and was amazed at the long list of potential side effects mentioned in the ad. Did a google search, and found that Humira sales in the most recent quarter were $2.3 billion (that's $9.2 billion annualized), and that it was being prescribed for many autoimmune disorders, including Crohn's disease and rheumatoid arthritis. I wonder if prurisol, if found effective for psoriasis, might also be effective for other autoimmune disorders.
If (there's that word again), prurisol is approved, it could be huge.
I went to Humira.com, and found the following list of side effects:
Important Safety Information About HUMIRA® (adalimumab)1
What is the most important information I should know about HUMIRA?
You should discuss the potential benefits and risks of HUMIRA with your doctor. HUMIRA is a TNF blocker medicine that can lower the ability of your immune system to fight infections. You should not start taking HUMIRA if you have any kind of infection unless your doctor says it is okay.
•
Serious infections have happened in people taking HUMIRA. These serious infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some people have died from these infections. Your doctor should test you for TB before starting HUMIRA, and check you closely for signs and symptoms of TB during treatment with HUMIRA. If your doctor feels you are at risk, you may be treated with medicine for TB.
•
Cancer. For children and adults taking TNF blockers, including HUMIRA, the chance of getting lymphoma or other cancers may increase. There have been cases of unusual cancers in children, teenagers, and young adults using TNF blockers. Some people have developed a rare type of cancer called hepatosplenic T-cell lymphoma. This type of cancer often results in death. If using TNF blockers including HUMIRA, your chance of getting two types of skin cancer (basal cell and squamous cell) may increase. These types are generally not life-threatening if treated; tell your doctor if you have a bump or open sore that doesn’t heal.
What should I tell my doctor BEFORE starting HUMIRA?
Tell your doctor about all of your health conditions, including if you:
•Have an infection, are being treated for infection, or have symptoms of an infection
•Get a lot of infections or infections that keep coming back
•Have diabetes
•Have TB or have been in close contact with someone with TB, or were born in, lived in, or traveled where there is more risk for getting TB
•Live or have lived in an area (such as the Ohio and Mississippi River valleys) where there is an increased risk for getting certain kinds of fungal infections, such as histoplasmosis, coccidioidomycosis, or blastomycosis
•Have or have had hepatitis B
•Are scheduled for major surgery
•Have or have had cancer
•Have numbness or tingling or a nervous system disease such as multiple sclerosis or Guillain-Barré syndrome
•Have or had heart failure
•Have recently received or are scheduled to receive a vaccine. HUMIRA patients may receive vaccines, except for live vaccines
•Are allergic to rubber, latex, or any HUMIRA ingredients
•Are pregnant, planning to become pregnant, breastfeeding, or planning to breastfeed
Also tell your doctor about all the medicines you take. You should not take HUMIRA with ORENCIA® (abatacept), KINERET® (anakinra), REMICADE® (infliximab), ENBREL® (etanercept), CIMZIA® (certolizumab pegol), or SIMPONI® (golimumab). Tell your doctor if you have ever used RITUXAN® (rituximab), IMURAN® (azathioprine), or PURINETHOL® (mercaptopurine, 6-MP).
What should I watch for AFTER starting HUMIRA?
HUMIRA can cause serious side effects, including:
•Serious infections. These include TB and infections caused by viruses, fungi, or bacteria. Symptoms related to TB include a cough, low-grade fever, weight loss, or loss of body fat and muscle.
•Hepatitis B infection in carriers of the virus. Symptoms include muscle aches, feeling very tired, dark urine, skin or eyes that look yellow, little or no appetite, vomiting, clay-colored bowel movements, fever, chills, stomach discomfort, and skin rash.
•Allergic reactions. Symptoms of a serious allergic reaction include hives, trouble breathing, and swelling of your face, eyes, lips, or mouth.
•Nervous system problems. Signs and symptoms include numbness or tingling, problems with your vision, weakness in your arms or legs, and dizziness.
•Blood problems. Symptoms include a fever that does not go away, bruising or bleeding very easily, or looking very pale.
•Heart failure (new or worsening). Symptoms include shortness of breath, swelling of your ankles or feet, and sudden weight gain.
•Immune reactions including a lupus-like syndrome. Symptoms include chest discomfort or pain that does not go away, shortness of breath, joint pain, or rash on your cheeks or arms that gets worse in the sun.
•Liver problems. Symptoms include feeling very tired, skin or eyes that look yellow, poor appetite or vomiting, and pain on the right side of your stomach (abdomen).
•Psoriasis (new or worsening). Symptoms include red scaly patches or raised bumps that are filled with pus.
Call your doctor or get medical care right away if you develop any of the above symptoms.
Common side effects of HUMIRA include injection site reactions (redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, rash, and nausea. These are not all of the possible side effects with HUMIRA. Tell your doctor if you have any side effect that bothers you or that does not go away.
Remember, tell your doctor right away if you have an infection or symptoms of an infection, including:
•Fever, sweats, or chills
•Muscle aches
•Cough
•Shortness of breath
•Blood in phlegm
•Weight loss
•Warm, red, or painful skin or sores on your body
•Diarrhea or stomach pain
•Burning when you urinate
•Urinating more often than normal
•Feeling very tired
HUMIRA is given by injection under the skin.
Actually the math is correct. I did not talk about percentages, I talked about a factor of 3-5 on the upside, and a factor of 3-5 on the downside.
In other words, if early Kevetrin results are favorable, the SP could be 3X or 5X the current share price = ~ $3 to $5.
If early kevetrin results are unfavorable, the SP could be $1/3 (=$0.33) or $1/5 (=$0.2).
While it is certainly true that the SP cannot go below zero, someone who invested their entire portfolio in CTIX, as apparently some on this board have done, would need a 500% increase in the share price just to get their portfolio back to where it is today if the SP were to tank to $0.2 on bad news.
If Kevetrin is a major success, the upside here is fantastic, but I would urge everyone not to spend all of their time fantasizing about being rich if it succeeds, but to also spend some time thinking about what their financial situation would be if Kevetrin fails.
Never fall in love with a stock.
A1
Here's my SWAG at chances of success:
Kevetrin: 0.15
Prurisol: 0.2
Rest of pipeline: 0.1
So overall chance of failure is 0.85*0.8*0.9 = 0.612.
Of course, the results from the different drugs will come at different times, so the situation is more complicated.
If there are early indications that kevetrin has a favorable safety and efficacy profile, the SP could jump by a factor of 3-5 by Xmas. If there are early indications of problems with kevetrin, the SP could drop by a similar factor.
It's also quite possible that kevetrin (or prurisol, or the rest of the pipeline) could have favorable phase 1 results, but will fail during later stage trials. This is why, if the phase 1 trials are favorable, and the SP jumps, I plan to sell a fraction of my holdings, such that my remaining shares are essentially free.
I've seen far too many 'can't-lose' stocks crash and burn to risk more than a smallish fraction of my portfolio on one.
A1
The key word is 'if'. If kevetrin is effective at treating and substantially delaying progression of a variety of cancers, this stock could be a 100 bagger. But everyone needs to remember that the likelihood of this happening is substantially less than 50%.
So, while it's great to fantasize about how rich we'll be if kevetrin is successful, we need to remember that (based on the track record of drugs entering phase 1 trials) it's unlikely that kevetrin will become a successsful drug.
In other words, don't bet the ranch on CTIX. Only risk what you can afford to lose, as the odds are, you will lose. I would suggest investing no more than 5-10% of your portfolio in this stock (I'm near the upper range of that percentage myself).
A1
DR F - Thanks for the reply.
As I recall, the testing done on Kevetrin was done on nude mice, not on SCID mice.
Are nude mice as good predictors for humans as SCID mice?
A1
Ratio between NOAEL and MTD?
The one item that concerns me about the data presented so far on Kevetrin is he following on Cellceutix's web site:
» A GLP repeated dose toxicity study in rats with 5 weekly doses of Kevetrin, in the range of 60 to 120 mg/kg given intravenously showed a NOAEL of Kevetrin of 90 mg/kg.
» A GLP repeated dose toxicity study in dogs with 5 weekly doses of Kevetrin, in the range of 5 to 60 mg/kg given intravenously showed a NOAEL of 5 mg/kg.
(NOAEL stands for No Observed Adverse Effects Level, MTD stands for Maximum Tolerabe Dose).
The doses used on the Kevetrin studies in mice were at the 200 mg/kg level, higher than the NOAEL in rats, and much higher than the NOAEL in dogs. So this raises some concern in my mind that the effective dose in humans may be above the MTD. Does anyone have any information on typical ratios between NOAEL's and MTD's?
Thanks,
A
Clinical Trials Going Active for Cellceutix Anti-Cancer Drug Kevetrin.
CTIX PR
A1
Reason for low market cap?
Came across this one recently, still doing DD.
Seems to me that clinical results and recent NDA submission support a higher market cap. The low mkt cap indicates to me that there are substantial doubts about DCTH's future. Some of the issues I've identified are:
1) Potential for rejection of their recently filed NDA
2) Cash burn - likely will need to raise more cash prior to FDA action on their NDA.
3) Lack of uptake of the treatment in Europe. If FDA approval is denied or delayed, how will this affect the success of the product in Europe?
4) Possibility that more data on generation 2 filter will be required by FDA.
Any other potential gotchas?
TIA
A1
No need for conspiracy theories here. All you have to do is look at their balance sheet.
http://www.otcmarkets.com/stock/CDOC/financials#
Less than $8 million in current assets, and more than $23 million in current liabilities.
A1
Interesting report - ORT appears to have a lot of potential, but a lot of things have to go right for it to realize its potential. Definitely a high-risk, high-reward play.
A1
I received the same message, and replied with my condolences.
A1
Abn; Since you have not provided detailed $ amounts,
I was able to get some numbers from another tree owner.
This tree owner had ~ 40 trees left per original 100 trees planted, and received ~ $2000 dollars per original 100 trees - less than the tree owner originally paid many years ago. This works out to $50/tree. The amount paid to the tree owner is only ~ 12% of what is projected on TATF's website for the current value trees of this age, and only ~ 35% of my estimate for the true market value of the trees (so not only is TATF overstating the current value of its trees by a factor of ~ 3, they only paid tree owners ~ 1/3 of the actual value of the trees they cut).
Another possibility is that TATF paid tree owners a reasonable price for the trees, but that the trees only contained 1/3 as much wood as the projections on TATF's website project they should have at this age.
A1
How do you know the processors can handle it? Can you point to any JBII literature that states the processors can handle it?
Abnrgrrvn;
Would you care to share the price per cubic meter you received for your teak?
Also, you mentioned that your remaining trees continue to be well-looked after. All the other reports I've received are that no thinning or other maintenance is being done on TATF's farms.
Finally, how did you contact TATF? I have e-mailed and called them several times in the past few months. None of my e-mails in this time frame have received responses. When I called, no live person answered the phone - just an answering machine. When I left messages, my calls were not returned. I know of several other TATF tree owners who've had the same experience.
Anyone can call or e-mail TATF to verify my comments about their lack of response. Their e-mail is trees@tropicalhardwoods.com. Their phone numbers are 1-800-788-4918 and 011-506-2289-9624
It seems like you're a special case here - the only TATF tree owner I know of who is receiving distributions and the only TATF tree owner who is receiving communications from the company. Why is that?
A1
How much plastic feedstock per week does JBII need?
In order to keep the 2 P2O processors running, with 75% uptime, at 4000 lbs/hr (= 2 tons/hr), we have
168 hrs/week *0.75 = 126 hrs/week of uptime
126 * 2 tons/hr * 2 processors = 504 tons of waste plastic feedstock per week.
It's already been established that JBII cannot accept unsorted plastic feedstock from recycling centers (because this might contain PVC, which JVC is not permitted to run through its P2O processors).
So, in order to keep 2 processors running at 75% uptime, JBII needs to source ~ 500 tons/week of waste plastic from high-volume point source producers (meat-packing plants, etc) who can guarantee that their plastic waste streams do not contain PVC.
Five hundred tons a week is a lot of plastic, and I suspect they will have substantial difficulty sourcing this amount of waste plastic from said point-source producers.
Yes, in the last conference call, JB said waste plastic was '(pause) abundant', but what exactly does that mean? To my mind, 50 tons a week is 'abundant', but thats only 10% of what JBII needs.
We shall see when the next 10 Q is filed.
A1
JBII is a gold mine*
*Definition of a gold mine: A hole in a ground with a liar standing next to it.
A1
Which means that JBII cannot use unsorted plastic from the large mixed plastic waste stream that is currently going into landfills. This means that a large fraction of the plastic waste generated today is not available to JBII as feedstock.
No, sorry, you are wrong!
All, or at least a large majority, of the plastics run through JBII's processors, would otherwise end up in a landfill.
How is the PVC in a mixed load of 'unwashed, unsorted plastic waste' directed towards the landfill, while the rest of the plastic is directed towards JBII's reactors, without sorting?
Magic?
Your reply completely fails to address my point.
Let me make it as simple as I can:
1) JBII's air permit does not allow it to run PVC (a halogenated plastic) in its reactors.
2) PVC is part of the plastic waste stream.
3) If JBII runs unsorted plastics in its reactors, as it has repeatedly claimed it is able to to, it will invevitably run PVC through its reactors, in violation of its air permit.
4) Therefore, if JBII is not to violate its air permit, it cannot run unsorted plastics through its reactors.
A1
JBII caught in a lie?
According to JBII's 8-K filed on June 11, 2011 (and linked to in loanrangers's excellent post 168904), JBII's air permit contains the following clause:
'The plastic waste allowed to be converted into fuel is described in the permits as: waste plastic material Type 2 (HDPE), Type 4 (LDPE), Type 5 (PP), and other plastics not expressly prohibited by the JBI's Air Permit. At this time, plastics containing halogens are prohibited by the Air Permit'
Chlorine is a halogen; therefore PVC, which contains chlorine, is not allowed to be processed by their P2O reactors.
JBII has repeatedly stated that their reactors can process 'unwashed, unsorted plastic waste'. If the plastic waste is unsorted, JBII cannot ensure that it does not contain PVC.
Therefore, if JBII is not to violate its air permit, it cannot run unwashed, unsorted plastic waste in its reactors.
A1
Is JBII selling fuel oil or salad oil?
JBII keeps on posting pictures of their fuel in beakers. Are they selling fuel oil or salad oil? If they want to be credible, they need to show multi-thousand gallon tanks of fuel, not beakers of fuel, and their financial results need to reflect sales of large quantities of fuel on a regular basis.
Until this happens, I will remain a skeptic.
A1
Yes, with customer agreements signed and even one processor running full time, it should be straightforward to generate several hundred thousand $ this quarter in revenue. With two processors now constructed, it should be be possible to do over $1 million this quarter in P2O revenue, and over $2 million next quarter.
The very anemic revenue numbers posted so far are why I no longer own shares in JBII, despite all the positive PR's and presentations from the company - the financial results don't jive with the reported progress. I still monitor the situation, and may get back in if revenues start to climb as they should.
A1
Rawnoc;
When will all Heaven break out?
A1
Predictions and hope and beliefs (and fuel sales agreements) are great...
But they're no substitute for actual sales and profitability, which JBII has yet to deliver.
Yes, the 83.6% gross margin on P2O sales last quarter is massive, but the $80k of P2O sales last quarter is minuscule. To support their current market cap, JBII needs to ramp their P2O sales something like 50-100 fold, which would mean annualized sales of $16-32 million, compared to their market cap of $135 million. A production ramp of this magnitude is non-trivial, and JBII has not demonstrated they can pull it off.
A1
Agreements to sell fuel are well and good...
But what really matters is actual sales of P2O fuel. JBII currently has a market cap of $135 million. To support this valuation, they need to quickly ramp up their P2O fuel sales. Last quarter, they sold only $80k of P2O fuel, which is equivalent to less than 10% of the stated capacity of 1 P2O processor. On an annualized basis, their market cap to P2O sales ratio is 420 - an exceedingly high number. Yes, they have sales from Pakit and Javaco, but it's P2O that's driving the share price, especially since they're planning to sell or close the other divisions.
Any prediction on what their fuel sales will be this qtr? What about Q1 of 2012? Unless they quickly ramp their fuel sales to millions of $/quarter, and become cash flow positive, it's hard to see the SP staying as high as it is. If they do demonstrate that they can consistently sell significant volumes of P2O fuel at margins high enough to cover their overhead, the upside is large.
A1
Re: New link for teak prices in Costa Rica
Cost Rica teak prices (ONF)
After re-reading the ONF publication, I realized that I had used the wrong prices in post 3388. The 'patio' prices referred to in the ONF publication were prices at the sawmill, not at the tree farm (my spanish is a little rusty). So the more relevant prices are in the pie, or field.
The correct prices are: ~$231/cubic meter (~$0.55/bd ft) for logs 20-29 cm in diameter, and ~ $323/cubic meter (~$0.76/bd ft) for logs > 30 cm in diameter.
A1
New link for teak prices in Costa Rica
The link to OLAT (contained in post 3333), that provided teak prices in Costa Rica, is broken.
I found another source for Costa Rica teak prices, published by the Costa Rican forestry agency (ONF).
Costa Rica teak prices (ONF)
Unfortunately, the prices are in Costa Rican Colones per pmt. One pmt is equivalent to 1/462 cubic meters.
Doing the conversion (from table 2 in the report), the price for teak logs on the patio (ie cut, but not loaded into containers) is ~ $365/cubic meter for logs 20-29 cm in diameter, and ~ $500/cubic meter for logs > 30 cm (~ 12 inches) in diameter.
A1
I think the big fear with all of the MREIT's is the potential for a freeze up in the short term lending (Repo) market, similar to what happened in 2008.
According to their most recent presentation,
AGNC Q2 report
AGNC is borrowing about $35 billion in the Repo market, with a weighted average maturity of 20 days. So AGNC, like all MREIT's, is constantly rolling over these short term loans. If the Repo market froze up, AGNC would be forced to default on its loans, with presumably drastic consequences for shareholders. Looking back to 2008-2009, the share price took quite a ride. Of course, it recovered nicely, but who knows what the future holds.
A1
Lots of waste plastic pyrolysis machines for sale on Alibaba
Alibaba ads for plastic pyrolysis equipment
Also there are quite a few US patents relating to this technology
USPTO search page
If you search for 'plastic' and 'pyrolysis' in the abstract field at the above web page, you'll find a number of patents for equipment and processes that appear quite similar to what JBII is doing.
This is a good news/bad news situation. The fact that there's so much activity in this area probably means that pyrolysis of plastic into fuel is feasible, but it also means that JBII could be facing a lot of competition.
A1
Ragger tail is only a small part of RockTenn's waste stream.
I did some more searching online, and found some information that strongly indicates that only a small fraction of the 'thousands of tons per day' of plastic that RockTenn produces is ragger tail.
First, I found the following report from an intern at the Cedar River Paper Co plant (currently owned by Weyerhaeuser).
ragger tail report
This report states that the plant produces ~ 4000 tons/year of ragger tail, or about 11 tons/day. The plant is located at
4600 C St SW Cedar Rapids IA
I then found the following press release about this plant that states the plant uses about 700,000 tons of paper annually.
Cedar River Recycled Paper Use
So the percentage of ragger tail produced from waste paper is 4000/700000 = 0.57%
I then looked on the Rock Tenn website, and found the following
Rock-Tenn recycling quantity /
in which it states that Rock-Tenn recycles about 9 million tons of waste annually. Even if this were entirely waste paper (it's not), they would only produce 9 million tons * 0.57% = 51000 tons per year, or ~ 140 tons/day of ragger tail from all of their facilities combined.
In JBI's press release announcing the Rock-Tenn agreement, they state
'RockTenn's paper mills and MRFs (Material Recovery Facilities) currently produce thousands of tons of plastic per day'
JBI - RockTenn Press Release
Bottom line is that only a few percent of the thousands of tons of waste plastic produced per day by RockTenn is ragger tail.
A1
You referenced a patent application, not a patent. It's not clear that there's anything in the patent application you referenced that's new and non-obvious to those skilled in the art (ie, we don't know if the patent will be granted or not).
A1
What's so bad about ragger tail?
There's been a lot of discussion about how ragger tail is so bad. It's not clear to me that ragger tail would be a problem for a P2O processor.
According to this website
Ragger Tail Definition
ragger tail is comprised of mixed plastic and steel wire. If this were fed into a P2O processor, the plastic would be processed as normal. The steel would not melt, would be left inside the processor, and would be removed with the rest of the residue. Since the residue running pure plastic is ~2% of the input weight of the plastic, if 20% of the weight of the ragger tail was steel, ~ 90% by weight of the residue in the process chamber would be steel. JBII has stated that this residue can be removed hot, so the processor does not need to be cooled to remove it.
Assuming the steel is 20% by weight of the ragger tail, a 30 tpd processor that is fed 100% ragger tail would process 24 tpd of plastic ( producing ~ 24,000 liters or ~ 145 barrels of fuel per day), with ~ 6 tpd of scrap steel that could be removed from the reaction chamber along with the rest of the residue.
I checked online, and scrap steel is currently selling for ~ $400/ton. So the revenue per day from a machine at an RKT facility running on 100% ragger tail would be (assuming JBII gets paid $75/barrel)
145*75 (= $10875) for the fuel produced + 6*400 (= $2400) for the scrap steel produced = $13275
Running 100% plastic through a P20 processor would result in 30000 liters of fuel per day, or ~ 183 barrels. Revenue per day in this case would be 183*75 = $13725 - only about 3.5% different than the ragger tail case.
Even if the scrap steel could not be sold, and had to be landfilled at a cost of $50/ton the ragger tail revenue per day would be 145*$75 - 6*$50 = $10575 per day, or about 23% less than the pure plastic case. Hardly seems like a disaster to me - this still works out to an annual gross profit of ~$3.8 million per machine (assuming 24/7 operation). If we make a more conservative assumption that the processor would run 6 days/week, 20 hours/day, this still works out to an annual gross profit of ~ $2.75 million, running 100% ragger tail.
In fact, I wouldn't be surprised if RKT had already shipped ragger tail to JBII's NF facility, and JBII had demonstrated that it could process it. This may very well be why RKT signed the deal with JBII in the first place.
A1
How long to bring up the first P2O processor at an RKT site?
My guess is that this could take a year or more. Permits could take up most of that time, especially since the P2O processor is a new and unknown quantity to regulators in all states, except for NY state.
According to RKT's website, the closest recycling facility to NY state they have is in Philadelphia, PA, and the next closest is in Columbus, OH.
A1
Re: Another Chinese P2O company.
I looked at your link to the patents, and saw the following at the bottom of the page:
'All information on this Web site is copyright 2004 by Beijing Roy Environment Technology Co.,Ltd..'
Then I noticed that all of the dates on their photographs were from April of 2003.
Then I clicked on the 'News' link on their website, and saw the following:
'Under updating....... '
Hardly looks like a going concern to me.
A1
Re: Another Chinese P2O company.
Amazing - they've been turning plastic into oil for 18 years, and no-one has heard of them. Maybe their process doesn't work very well?
Just a thought.
A1
BAJ.TO up 5% today...
on 3X normal volume on a sharply down day in the market.
Interesting.
A1
The diesel specifications look excellent. From what I've read, diesel with a cetane rating of > 47 qualifies as premium diesel, and can be sold at a premium to regular diesel. Also, standard diesel has an API number of ~ 40. JBII's diesel has an API number of 34-39. Lower API numbers correspond to a higher density, and a higher energy content per gallon. Of course the sulfur content is excellent as well.
The wholesale price for diesel is ~ $2.75/gallon. If JBII can make 100 barrels per day of diesel, that works out to $11,550 per day of revenue. That's probably on the optimistic side, as not all of their product is diesel. Still, things are looking good!
A1
How much oil/fuel production will be enough?
As some other posters on this board have noted, a key issue is how much oil JBII has been producing from its single operational P2O system. This system has the capability to produce ~ 100 barrels (= 4200 gallons) per day. When JBII reports their Q2 results, which I understand will happen in the middle of August, I would be disappointed if they reported less than 1000 barrels of production in Q2, although if they reported at least 1k barrels of production so far in Q3, that might also be acceptable.
Given all of the announcements JBII has made about their capability, the time to demonstrate that they can actually do what they say is now. If they fail to announce significant production from their processor when they report their Q2 results, I tend to think many, including myself, will lose faith in this co, and the SP will tank.
My question to others on this board is:
How much fuel production will JBII have to report when they report their Q2 results for you not to lose faith in this co?
A1
Unfortunately, this is typical of TATF.
There's no mention on their website that they've stopped thinning trees, or that they're not allowing tree owners to visit their trees, even though items 4 and 21 of their tree order form state:
'As your trees grow, it is silviculturally recommended to periodically remove some of your trees in thinning harvests to make room for the continued growth of your remaining trees.'
and
'As an owner of trees in our plantation, you or anyone you may designate have the right to inspect your trees at any reasonable time.'
Most of TATF's updates to their website have been in the form of new, 'very special opportunity, for a limited time' offers to sell trees at a 'discount', just like the latest offer. Meaningful updates for existing tree owners are few and far between, and the information about our investment we have been able to glean has been uniformly bad.
A1
PCT.V PCTZF.PK Another timber investment opportunity.
Prima Colombia Hardwood is a fairly new company, set up to do heli-logging in Colombia. Might be worth a look.
A1